CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients

Medical Oncology

Volumn 30, Issue 4, 2013, Pages

  Shi, Wei Lin ^a   Li, Jian ^a   Du, Yong Jie ^a   Zhu, Wen Fang ^a   Wu, Yan ^b   Hu, Yi Ming ^a   Chen, Yong Chang ^b  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Chemotherapy; Circulating tumor cell; CK 19 mRNA; Predictor; Prognosis; Small cell lung cancer

Indexed keywords

CISPLATIN; CYTOKERATIN 19; ETOPOSIDE; MESSENGER RNA; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SKULL IRRADIATION; TREATMENT RESPONSE; BLOOD; CASE CONTROL STUDY; GENETICS; KAPLAN MEIER METHOD; LUNG NEOPLASMS; METABOLISM; MULTIVARIATE ANALYSIS; PATHOLOGY; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME; TUMOR EMBOLISM;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KERATIN-19; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASTIC CELLS, CIRCULATING; RNA, MESSENGER; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84886745405     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0755-9     Document Type: Article

References (28)

1. Chua YJ, Steer C, Yip D. Recent advances in management of small-cell lung cancer. Cancer Treat Rev. 2004;30:521-43. (Pubitemid 39157853)
2. Li J, Dai C-H, Chen P, Wu J-N, Bao Q-L, Qiu H, Li X-Q. Survival and prognostic factors in small cell lung cancer. Med Oncol. 2010;27:73-81.
3. Rosti G, Bevilacqua G, Bidoli P, Portalone L, Santo A, Genestreti G. Small cell lung Cancer. Ann Oncol. 2006;17(Suppl 2):ii5-10.
4. Bremnes RM, Sundstrom S, Aasebl U, Kaasa S, Hatlevoll R, Aamdal S. The value of prognostic factors in small cell lung cancer: results from a randomized multicenter study with minimum 5 year follow-up. Lung Cancer. 2003;39:303-13. (Pubitemid 36279450)
5. Ustuner Z, Saip P, Yasasever V, Vural B, Yazar A. Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients. Med Oncol. 2008;25:394-9.
6. Ando S, Suzuki M, Yamamoto N, Iida T, Kimura H. The prognostic value of both neuron-specific enolase (NSE) and cyfra21-1 in small cell lung cancer. Anticancer Res. 2004;24(3B):1941-6. (Pubitemid 38954614)
7. Jørgensen LG, Osterlind K, Genollá J, Gomm SA, Hernández JR, Johnson PWM, Løber J, Splinter TAW, Szturmowicz M. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariate analysis on data from nine centers. Br J Cancer. 1996;74:463-7. (Pubitemid 26254580)
8. Fizazi K, Cojean I, Pignon J-P, Rixe O, Gatineau M, Hadef S, Arriagada R, Baldeyrou P, Comoy E, Chevalier TL. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung cancer. Cancer. 1998;82:1049-55.
9. Bharti A, Ma PC, Maulik G, Singh R, Khan E, Skarin AT, Salgia R. Haptoglobin α-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res. 2004;24:1031-8. (Pubitemid 38624933)
10. Salven P, Ruotsalainen T, Mattson K, Joensuu H. High pretreatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer. 1998;79:144-6. (Pubitemid 28201685)
11. Hatzakis KD, Froudarakis ME, Bouros D, Tzanakis N, Karkavitsas N, Siafakas NM. Prognostic value of serum tumor markers in patients with lung cancer. Respiration. 2002;69:25-9. (Pubitemid 34158384)
12. Wójcik E, Kulpa JK, Sas-korczynska B, Korzeniowski S, Jakubowicz J. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer. Anticancer Res. 2008;28:3027-34.
13. Moss AC, Jacobson GM, Walker LE, Blake NW, Marshall E, Coulson JM. SCG3 Transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer. Clin Cancer Res. 2009;15:274-83.
14. Shibayama T, Ueoka H, Nishii K, Kiura K, Tabata M, Miyatake K, Kitajima T, Harada M. Complementary roles of prognastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) in diagnosis and prognosis of small cell lung cancer (SCLC). Lung Cancer. 2001;32:61-9. (Pubitemid 32224840)
15. Xenidis N, Ignatiadis M, Apostolaki S, Perraki M, Kalbakis K, Agelaki S, Stathopoulos EN, Chlouverakis G, Lianidou E, Kakolyris S, Georgoulias V, Mavroudis D. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J Clin Onco. 2009;27:2177-83.
16. Stathopoulou A, Gizi A, Perraki M, Apostolaki S, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clin Cancer Res. 2003;9:5145-51. (Pubitemid 37413564)
17. Saloustros E, Perraki M, Apostolaki S, Kallergi G, Xyrafas A, Kalbakis K, Agelaki S, Kalykaki A, Georgoulias V, Mavroudis D. Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse. Breast Cancer Res. 2011;13:R60.
18. Xenidis N, Perraki M, Kafousi M, Apostolaki S, Bolonaki I, Stathopoulou A, Kalbakis K, Androulakis N, Kouroussis C, Pallis T, Christophylakis C, Argyraki K, et al. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol. 2006;24:3756-62. (Pubitemid 46622314)
19. Ge MJ, Shi D, Wu QC, Wang M, Li LB. Observation of circulating tumor cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in perioperative period. J Cancer Res Clin Oncol. 2006;132:248-56. (Pubitemid 43144261)
20. Chen T-F, Jiang G-L, Fu X-L, Wang L-J, Qian H, Wu K-L, Zhao S. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor. Lung Cancer. 2007;56:105-14. (Pubitemid 46356633)
21. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Glabbeke MV, van Oosterom AT, Christian MC, Gwyther SG. New guideline to evaluate the response to treatment in solid tumors: European Organization for Research and treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Nalt Caner Inst. 2000;92:205-16.
22. -â-â-Ct method. Methods. 2001;25:402-8. (Pubitemid 34164012)
23. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Cliark MC. For the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur J Cancer. 2005;41:1690-6. (Pubitemid 41132629)
24. Ring AE, Zabaglo L, Ormerod MG, Smith IE, Dowsett M. Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer. 2005;92:906-12. (Pubitemid 40462638)
25. Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the Cell Search system. Clin Cancer Res. 2007;13:920-8. (Pubitemid 46340368)
26. Hou J-M, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJC, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol. 2012;30:525-32.
27. Hillermann TJN, Pore MM, van den Berg A, Timens W, Boezen HM, Liesker JJW, Schouwink JH, Wijnands WJA, Kerner GSMA, Kruyt FAE, Tissing H, Tibbe AGJ, et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol. 2012;23:2937-42.
28. Alix-Panabieres C, Sabine Riethdorf S, Pantel K. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res. 2008;14:5013-21.